The Board of Directors of Vijaya Diagnostic Centre at their meeting held today have inter-alia considered and approved the terms and conditions of the Share Purchase agreement (SPA) between the Company, P H Diagnostic Centre (P H / Target) and its Promoters/Shareholders (Sellers) or the acquisition of 100% stake in “P H”. Post completion of the aforesaid acquisition, “P H” will become wholly-owned subsidiary
(WOS) of the Company.
The cost of acquisition is Rs 134.65 crore. Additionally, Rs 12.85 crore shall be infused into the Target Company by way of either equity or
loan to pay the existing debt.